Graft-Versus-Host Disease (GVHD): Symptoms, Causes, and Treatment
What is Graft-Versus-Host Disease?
Graft-versus-host disease (GVHD) is a serious and potentially life-threatening complication that can occur after certain types of medical treatments, most commonly bone marrow or stem cell transplants. It happens when the donated cells (the graft) recognize the recipient's body (the host) as foreign and attack it, similar to how the immune system fights infections.
GVHD can be acute (occurring within the first 100 days after transplant) or chronic (developing later and lasting longer). According to the National Cancer Institute (NCI), acute GVHD affects about 30-50% of transplant recipients, while chronic GVHD can affect up to 70% of long-term survivors.
Common Causes
GVHD primarily occurs after procedures involving donor cells. Here are the most common causes:
- Allogeneic stem cell transplant: The most common cause, where stem cells are donated by another person (not the patient).
- Bone marrow transplant: Similar to stem cell transplants, using bone marrow from a donor.
- Cord blood transplant: Stem cells from umbilical cord blood can also trigger GVHD.
- Haploidentical transplant: Transplants from a partially matched family member (e.g., parent or child).
- Mismatched donor transplants: Higher risk when the donor and recipient are not well-matched.
- Donor lymphocyte infusion (DLI): A treatment where donor white blood cells are given to boost the immune system after transplant.
- Solid organ transplants (rare): In rare cases, GVHD can occur after liver or intestinal transplants if lymphoid tissue is included.
- Blood transfusions (very rare): In immunocompromised patients, transfusions from blood relatives may rarely cause GVHD.
According to the Centers for Disease Control and Prevention (CDC), the risk of GVHD increases with:
- Older age of the donor or recipient.
- Gender mismatch (e.g., male donor to female recipient).
- Use of unrelated or mismatched donors.
- Certain infections (e.g., cytomegalovirus) before or after transplant.
Associated Symptoms
GVHD can affect multiple organs, and symptoms vary depending on whether it is acute or chronic.
Acute GVHD Symptoms
These typically appear within the first 3 months after transplant and may include:
- Skin:
- Rash, often starting on the palms, soles, ears, or face.
- Redness, itching, or peeling skin.
- Blistering or severe skin sensitivity.
- Liver:
- Jaundice (yellowing of the skin or eyes).
- Dark urine or pale stools.
- Abdominal pain or nausea.
- Digestive tract:
- Severe diarrhea (sometimes bloody).
- Nausea, vomiting, or loss of appetite.
- Abdominal cramps or pain.
Chronic GVHD Symptoms
These develop later (usually after 3 months) and can persist long-term. Symptoms may include:
- Skin and nails:
- Dry, thickened, or tightened skin.
- Skin discoloration or scarring.
- Nail changes (ridging, splitting, or loss).
- Mouth and eyes:
- Dry mouth or eyes (similar to Sjogren's syndrome).
- Mouth sores or sensitivity to spicy/acidic foods.
- Vision changes or eye irritation.
- Lungs:
- Shortness of breath or chronic cough.
- Bronchiolitis obliterans (a serious lung condition).
- Joints and muscles:
- Joint pain, stiffness, or muscle weakness.
- Limited range of motion.
- Genital area:
- Vaginal dryness or irritation in women.
- Scarring or strictures in men.
Chronic GVHD can also cause fatigue, weight loss, and an increased risk of infections due to a weakened immune system.
When to See a Doctor
If you or a loved one has undergone a stem cell or bone marrow transplant, it’s important to monitor for signs of GVHD closely. Contact your healthcare provider if you experience:
- A new rash, especially if it spreads quickly or is painful.
- Persistent diarrhea, nausea, or vomiting.
- Yellowing of the skin or eyes (jaundice).
- Unexplained fever or signs of infection.
- Dryness, pain, or sores in the mouth or eyes.
- Shortness of breath or chronic cough.
- Joint pain or stiffness that limits movement.
Early detection and treatment of GVHD can significantly improve outcomes. Do not wait for symptoms to worsen before seeking medical advice.
Diagnosis
Diagnosing GVHD involves a combination of clinical evaluation, laboratory tests, and sometimes biopsies. Here’s how doctors typically approach diagnosis:
Medical History and Physical Exam
Your doctor will review your transplant history, symptoms, and perform a physical exam to check for signs like rash, jaundice, or mouth sores.
Laboratory Tests
- Blood tests: To check liver function (e.g., bilirubin, liver enzymes), kidney function, and complete blood count (CBC).
- Stool samples: If diarrhea is present, to rule out infections like Clostridium difficile.
- Viral tests: To check for infections such as cytomegalovirus (CMV) or Epstein-Barr virus (EBV), which can mimic or worsen GVHD.
Biopsies
A biopsy (removing a small tissue sample for examination) is often needed to confirm GVHD. Common biopsy sites include:
- Skin biopsy: For rash or skin changes.
- Liver biopsy: If liver enzymes are elevated.
- Gastrointestinal biopsy: Via endoscopy or colonoscopy for digestive symptoms.
- Mouth or eye biopsy: For chronic GVHD affecting these areas.
Imaging Tests
In some cases, imaging like chest X-rays or CT scans may be used to assess lung involvement.
Scoring Systems
Doctors often use scoring systems like the Glucksberg criteria (for acute GVHD) or the NIH Consensus Criteria (for chronic GVHD) to classify the severity and guide treatment.
Treatment Options
Treatment for GVHD aims to suppress the immune response, reduce inflammation, and manage symptoms. The approach depends on the severity (grade) and whether it is acute or chronic.
Medical Treatments
First-Line Treatments
- Corticosteroids: Such as prednisone or methylprednisolone, are the cornerstone of GVHD treatment. They reduce inflammation and suppress the immune system.
- Calcineurin inhibitors: Medications like tacrolimus or cyclosporine are often used alongside steroids to prevent or treat GVHD.
Second-Line Treatments
If first-line treatments fail, other options may include:
- Immunosuppressants: Such as mycophenolate mofetil, sirolimus, or methotrexate.
- Biologic therapies:
- Ruxolitinib (Jakafi): A JAK inhibitor approved for steroid-refractory GVHD.
- Ibrutinib (Imbruvica): Used for chronic GVHD.
- Extracorporeal photopheresis (ECP): A procedure where blood is treated with UV light to reduce immune activity.
- Monoclonal antibodies: Such as infliximab or rituximab, which target specific immune cells.
Supportive Care
- Infections: Antibiotics, antivirals, or antifungals to prevent or treat infections, as immunosuppression increases risk.
- Pain management: Medications to relieve pain from skin or joint involvement.
- Nutritional support: IV fluids or nutrition if digestive symptoms prevent eating.
- Physical therapy: To maintain mobility and strength, especially with chronic GVHD.
Home and Lifestyle Management
While medical treatment is essential, the following strategies can help manage symptoms at home:
- Skin care:
- Use mild, fragrance-free soaps and moisturizers.
- Avoid hot showers; opt for lukewarm water.
- Wear loose, soft clothing to reduce irritation.
- Mouth care:
- Rinse with a baking soda and water solution (1 tsp baking soda in 8 oz water) to soothe sores.
- Avoid alcohol-based mouthwashes, tobacco, and spicy/acidic foods.
- Use artificial saliva or sugar-free gum for dry mouth.
- Eye care:
- Use preservative-free artificial tears for dry eyes.
- Wear sunglasses to protect from wind and sun.
- Diet:
- Eat small, frequent meals if nausea or diarrhea is present.
- Avoid raw or undercooked foods to reduce infection risk.
- Stay hydrated, especially if experiencing diarrhea.
- Infection prevention:
- Wash hands frequently and avoid crowds or sick contacts.
- Follow your doctor’s recommendations for vaccinations (e.g., flu, pneumonia).
Prevention Tips
While GVHD cannot always be prevented, certain strategies can reduce the risk:
- Donor matching: Choosing a well-matched donor (e.g., a sibling with identical HLA typing) lowers GVHD risk.
- T-cell depletion: Removing T-cells (immune cells that cause GVHD) from the donor graft before transplant. However, this may increase infection or relapse risk.
- Prophylactic medications: Taking immunosuppressants like tacrolimus or cyclosporine after transplant to prevent GVHD.
- Reduced-intensity conditioning: Using lower doses of chemotherapy or radiation before transplant may reduce GVHD severity.
- Post-transplant monitoring: Regular follow-ups to catch early signs of GVHD.
- Avoiding donor lymphocyte infusions (DLI) unless necessary: DLI can trigger GVHD in some cases.
Discuss these options with your transplant team to determine the best prevention strategy for your situation.
Emergency Warning Signs
Seek immediate medical attention if you experience any of the following symptoms, as they may indicate severe GVHD or complications:
- Severe skin reactions:
- Widespread, painful rash or blistering.
- Skin peeling over large areas of the body.
- Gastrointestinal emergencies:
- Blood in stool or vomit.
- Severe diarrhea (more than 10-15 episodes per day) leading to dehydration (dizziness, extreme thirst, low urine output).
- Severe abdominal pain or vomiting that prevents eating/drinking.
- Liver failure signs:
- Severe jaundice (deep yellow skin/eyes) with confusion or bleeding.
- Swelling in the abdomen or legs (ascites/edema).
- Infection signs:
- High fever (over 100.4°F or 38°C) with chills.
- Signs of sepsis (rapid heart rate, low blood pressure, confusion).
- Respiratory distress:
- Severe shortness of breath or inability to breathe.
- Blue lips or fingernails (cyanosis).
- Neurological symptoms:
- Seizures, severe headache, or confusion.
These symptoms can indicate life-threatening complications. Call 911 or go to the nearest emergency room if you or your loved one experiences any of these warning signs.
Living with GVHD
GVHD can be a long-term challenge, but many people manage it successfully with medical care and lifestyle adjustments. Support groups, counseling, and working closely with your healthcare team can improve quality of life. Organizations like the Bone Marrow & Cancer Foundation and the Leukemia & Lymphoma Society offer resources and support for GVHD patients.